DnB Asset Management
RGNX icon

DnB Asset Management’s Regenxbio RGNX Stock Holding History

DnB Asset Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$232K Sell
19,365
-961
-5% -$7.97K ﹤0.01% 1131
2026
Q1 		$170K Sell
20,326
-5,286
-21% -$55.5K ﹤0.01% 1185
2025
Q4 		$369K Buy
25,612
+7,689
+43% +$95.8K ﹤0.01% 691
2025
Q3 		$173K Sell
17,923
-473
-3% -$4.18K ﹤0.01% 722
2025
Q2 		$151K Sell
18,396
-95
-0.5% -$795 ﹤0.01% 703
2025
Q1 		$132K Buy
18,491
+3,952
+27% +$29.4K ﹤0.01% 718
2024
Q4 		$112K Buy
14,539
+2,434
+20% +$22.9K ﹤0.01% 718
2024
Q3 		$127K Buy
+12,105
New +$148K ﹤0.01% 705

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

DnB Asset Management's RGNX Position: Q2 2026 in Review

DnB Asset Management reduced its Regenxbio (RGNX) stake by 4.7% in Q2 2026, selling an estimated $7.97K and leaving 19,365 shares worth $232K. The position accounts for ﹤0.01% of the portfolio, ranked #1131.

DnB Asset Management first reported a position in RGNX in Q3 2024 and has held it in 8 quarters since. The position peaked at $369K in Q4 2025. 112 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • DnB Asset Management held 19,365 shares of Regenxbio worth $232K as of Q2 2026.
  • DnB Asset Management sold 961 Regenxbio shares in Q2 2026, an estimated $7.97K.
  • Regenxbio made up ﹤0.01% of DnB Asset Management's portfolio in Q2 2026, its #1131 holding.
  • DnB Asset Management first reported a position in Regenxbio in Q3 2024 and has held it in 8 quarters since.
  • DnB Asset Management's Regenxbio position peaked at $369K in Q4 2025.
  • 112 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on DnB Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.